The effect of comorbidity on health-related quality of life for injury patients in the first year following injury: comparison of three comorbidity adjustment approaches

被引:36
|
作者
Haagsma, Juanita A. [1 ]
van Beeck, Ed F. [1 ]
Polinder, Suzanne [1 ]
Toet, Hidde [2 ]
Panneman, Martien [2 ]
Bonsel, Gouke J. [1 ]
机构
[1] Erasmus Univ, Erasmus Med Ctr, Dept Publ Hlth, NL-3000 CA Rotterdam, Netherlands
[2] Consumer Safety Inst, NL-1070 AD Amsterdam, Netherlands
来源
关键词
POPULATION; EUROQOL; EQ-5D;
D O I
10.1186/1478-7954-9-10
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Three approaches exist to deal with the impact of comorbidity in burden of disease studies - the maximum limit approach, the additive approach, and the multiplicative approach. The aim of this study was to compare the three comorbidity approaches in patients with temporary injury consequences as well as comorbid chronic conditions with nontrivial health impacts. Methods: Disability weights were assessed using data from the EQ-5D instrument developed by the EuroQol Group and derived from a postal survey among 2,295 injury patients at 2.5 and 9 months after being treated at an emergency department. We compared the observed and predicted EQ-5D disability weights in comorbid cases using data from injury patients with and without comorbidity who were restored from their injuries at 9 months follow-up. The predicted disability weights were calculated using the maximum limit approach, additive approach, and multiplicative approach. The intraclass correlation coefficient (ICC) was used to test whether the values of the observed disability weights and the three model-predicted disability weights were correlated. Results: The EQ-5D disability weight of injury patients increased significantly with the number of comorbid diseases. The ICCs of the additive, multiplicative, and maximum limit models were 0.817, 0.778, and 0.674, respectively. Although the 95% confidence intervals of the ICCs of the three models overlap, the maximum limit model seems to fit less well than the additive and multiplicative models. For mild to moderate chronic disease (disability weight below 0.21), the association between predicted and observed disability weights was low. Conclusions: Comorbidity has a high impact on disability measured with EQ-5D. Ignoring the effect of comorbidity restricts the use of the burden of disease concept in multimorbid populations. Gains from health care or interventions may be easily overestimated if a substantial number of patients suffer from additional conditions. The results of this study found that in accounting for comorbidity effects, all three models showed a strong association between the predicted and observed morbid disability weight, though the maximum limit model seems to fit less well than the additive and multiplicative models. The three models do not fit well in the case of mild to moderate pre-existing disease.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Functional Comorbidity Index and health-related quality of life in patients with obstructive sleep apnea
    Agrafiotis, Michalis
    Galanou, Artemis
    Fletsios, Dimosthenis
    Chassiotou, Anastassia
    Chloros, Diamantis
    Steiropoulos, Paschalis
    ADVANCES IN RESPIRATORY MEDICINE, 2022, 90 (01) : 9 - 16
  • [22] THE IMPACT OF PSYCHIATRIC COMORBIDITY ON HEALTH-RELATED QUALITY OF LIFE IN WOMEN WITH FIBROMYALGIA
    Ciapparelli, Antonio
    Bazzichi, Laura
    Consoli, Giorgio
    Marazziti, Donatella
    Dell'Osso, Mario
    Del Debbi, Alessandro
    Conversano, Ciro
    Paggini, Rosemma
    Massimetti, Gabriele
    Canytassi, Claudia
    Bombardieri, Stefano
    CLINICAL NEUROPSYCHIATRY, 2008, 5 (05): : 217 - 224
  • [23] Comorbidity and health-related quality of life in Somali women living in Sweden
    Demeke, Taye
    Osmancevic, Amra
    Gillstedt, Martin
    Krogstad, Anne Lene
    Angesjo, Eva
    Sinclair, Hakan
    Abd El-Gawad, Gamal
    Krantz, Emily
    Trimpou, Penelope
    Landin-Wilhelmsen, Kerstin
    SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE, 2019, 37 (02) : 174 - 181
  • [24] Alcoholism, HIV, and their comorbidity: Factors affecting health-related quality of life
    Rosenbloom, M. J.
    Sullivan, E. V.
    Sassoon, S. A.
    O'Reilly, A.
    Fama, R.
    Buss, J.
    Kemper, C. A.
    Deresinski, S. C.
    Pfefferbaum, A.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2006, 30 (06) : 91A - 91A
  • [25] The influence of COPD on health-related quality of life independent of the influence of comorbidity
    van Manen, JG
    Bindels, PJE
    Dekker, FW
    Bottema, BJAM
    van der Zee, JS
    Ijzermans, CJ
    Schadé, E
    JOURNAL OF CLINICAL EPIDEMIOLOGY, 2003, 56 (12) : 1177 - 1184
  • [26] A comparison of comorbidity indices based on health-related quality of life and mortality for predicting medical expenditures
    Rizio, Avery A.
    McCausland, Kristen L.
    Rendas-Baum, Regina
    QUALITY OF LIFE RESEARCH, 2018, 27 : S97 - S97
  • [27] Health care utilization and health-related quality of life of injury patients: comparison of educational groups
    van der Vlegel, Marjolein
    Spronk, Inge
    Groeniger, Joost Oude
    Toet, Hidde
    Panneman, Martien J. M.
    Polinder, Suzanne
    Haagsma, Juanita A.
    BMC HEALTH SERVICES RESEARCH, 2021, 21 (01)
  • [28] Health care utilization and health-related quality of life of injury patients: comparison of educational groups
    Marjolein van der Vlegel
    Inge Spronk
    Joost Oude Groeniger
    Hidde Toet
    Martien J. M. Panneman
    Suzanne Polinder
    Juanita A. Haagsma
    BMC Health Services Research, 21
  • [29] Perceived health-related quality of life and comorbidity in diabetic patients starting dialysis (CALVIDIA study)
    Martínez-Castelao, A
    Górriz, JL
    Garcia-López, F
    López-Revuelta, K
    De Alvaro, F
    Cruzado, JM
    JOURNAL OF NEPHROLOGY, 2004, 17 (04) : 544 - 551
  • [30] Comparison of Five Diagnosis Based Comorbidity Measures in Predicting Health-Related Quality of Life (HRQoL) in Multiple Sclerosis Patients
    Mehta, Hemalkumar B.
    Sura, Sneha D.
    Johnson, Michael L.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 10 - 10